To access this element change to forms mode OFF
Grant Award View - GA82056
Precision epigenetics: targeting the epigenome to treat disease
GA ID:
GA82056
Agency:
National Health and Medical Research Council (NHMRC)
Approval Date:
20-Apr-2020
Publish Date:
11-Jun-2020
Category:
Health and Medical Research
Grant Term:
1-Jan-2021 to 31-Dec-2025
Value (AUD):
$2,134,633.76
(GST inclusive where applicable)
One-off/Ad hoc:
No
Aggregate Grant Award:
No
PBS Program Name:
NHMRC 19/20 1.1 Health and Medical Research
Grant Program:
Investigator
Grant Activity:
Precision epigenetics: targeting the epigenome to treat disease
Purpose:
Epigenetic marks are changes made to the DNA that allow genes to be switched off in some cells and switched on in others. These marks are critical to normal development and often go wrong in disease. We aim to find genes that add epigenetic marks to the DNA and understand how they co-operate at the molecular level to switch genes off. Our focus is on one such gene, SMCHD1. We are developing new drugs against SMCHD1 to treat incurable neurodevelopmental disorder PWS and muscular dystrophy FSHD.
GO ID:
GO Title:
Investigator Grants 2020
Internal Reference ID:
GNT1194345
Selection Process:
Targeted or Restricted Competitive
Confidentiality - Contract:
Yes
Confidentiality Reason(s) - Contract:
Privacy Act 1988
Intellectual property
Intellectual property
Confidentiality - Outputs:
Yes
Confidentiality Reason(s) - Outputs:
Intellectual property
Grant Recipient Details
Recipient Name:
Walter and Eliza Hall Institute of Medical Research
Recipient ABN:
12 004 251 423
Grant Recipient Location
Suburb:
Parkville
Town/City:
Parkville
Postcode:
3052
State/Territory:
VIC
Country:
AUSTRALIA
Grant Delivery Location
State/Territory:
VIC
Postcode:
Country:
AUSTRALIA